BTTX
Better Therapeutics, Inc. Common Stock
BTTX
BTTX
Delisted
BTTX was delisted on the 15th of March, 2024.
14 hedge funds and large institutions have $7.16M invested in Better Therapeutics, Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 7 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
14
Holding in Top 10
–
Calls
$298K
Puts
–
Top Buyers
| 1 | +$1.18M | |
| 2 | +$540K | |
| 3 | +$160K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$68K |
| 5 |
Two Sigma Advisers
New York
|
+$24.8K |
Top Sellers
| 1 | -$1.01M | |
| 2 | -$465K | |
| 3 | -$401K | |
| 4 |
Millennium Management
New York
|
-$318K |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
-$212K |